Mimedx (MDXG) Receivables - Other (2017 - 2021)

Mimedx has disclosed Receivables - Other across 5 years of filings, most recently posting $400000.0 for Q2 2021.

• Receivables - Other for Q2 2021 came in at $400000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was $400000.0 (changed N/A YoY), and the FY2020 annual result was $200000.0, down 84.14% from the prior year.
• Receivables - Other came in at $400000.0 for Q2 2021 at Mimedx, down from $700000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $5.9 million in Q4 2017 to a low of $200000.0 in Q4 2020.
• The 5-year median for Receivables - Other is $980500.0 (2019), against an average of $2.0 million.
• Across the five-year window, Receivables - Other tumbled 84.14% in 2020 and grew 16.67% in 2021, its largest moves.
• Mimedx's Receivables - Other stood at $5.9 million in 2017, then slipped by 27.12% to $4.3 million in 2018, then slumped by 70.67% to $1.3 million in 2019, then sank by 84.14% to $200000.0 in 2020, then soared by 100.0% to $400000.0 in 2021.
• The last three Receivables - Other figures came in at $400000.0 (Q2 2021), $700000.0 (Q1 2021), and $200000.0 (Q4 2020), per Business Quant data.